UA97355C2 - Фармацевтическая композиция, включающая монтелукаст - Google Patents

Фармацевтическая композиция, включающая монтелукаст

Info

Publication number
UA97355C2
UA97355C2 UAA200809892A UAA200809892A UA97355C2 UA 97355 C2 UA97355 C2 UA 97355C2 UA A200809892 A UAA200809892 A UA A200809892A UA A200809892 A UAA200809892 A UA A200809892A UA 97355 C2 UA97355 C2 UA 97355C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
composition containing
montelukast
containing montelukast
active ingredient
Prior art date
Application number
UAA200809892A
Other languages
English (en)
Ukrainian (uk)
Inventor
Весна Крошельй
Рената Осолник
Турк Урска
Берек Франчи
Original Assignee
Крка, Товарна Здравил, Д.Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Товарна Здравил, Д.Д., Ново Место filed Critical Крка, Товарна Здравил, Д.Д., Ново Место
Priority claimed from PCT/EP2006/070045 external-priority patent/WO2007077135A1/en
Publication of UA97355C2 publication Critical patent/UA97355C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к фармацевтике и касается фармацевтической композиции, включающей фармацевтически приемлемую соль монтелукаста в виде частичек, имеющих значение d, меньше чем 250 мкм, способа ее получения и фармацевтической композиции в форме пилюли, которую получают прямым прессованием.
UAA200809892A 2005-12-30 2006-12-20 Фармацевтическая композиция, включающая монтелукаст UA97355C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05113112A EP1803457A1 (en) 2005-12-30 2005-12-30 Pharmaceutical composition containing montelukast
PCT/EP2006/070045 WO2007077135A1 (en) 2005-12-30 2006-12-20 Pharmaceutical composition containing montelukast

Publications (1)

Publication Number Publication Date
UA97355C2 true UA97355C2 (ru) 2012-02-10

Family

ID=35658888

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200809892A UA97355C2 (ru) 2005-12-30 2006-12-20 Фармацевтическая композиция, включающая монтелукаст

Country Status (3)

Country Link
EP (1) EP1803457A1 (ru)
NO (1) NO20083213L (ru)
UA (1) UA97355C2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006337648A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of montelukast sodium
CN101732268B (zh) * 2010-01-09 2012-12-05 鲁南制药集团股份有限公司 一种孟鲁司特钠片剂及其制备方法
CA2785694C (en) * 2010-02-26 2013-12-17 Toray Industries, Inc. Coated solid montelukast preparation
CN108888602B (zh) * 2018-08-16 2021-04-06 海南锦瑞制药有限公司 一种孟鲁司特钠制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347856C (en) * 1998-11-13 2009-02-17 Jagotec Ag Dry powder for inhalation
JP2006509716A (ja) * 2002-03-12 2006-03-23 マイクロドース・テクノロジーズ・インコーポレーテッド 吸入で同時投与した薬剤を特定部位へ届ける方法
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
IL174758A (en) * 2003-10-10 2012-09-24 Synthon Bv Crystalline form of montelukast, pharmaceutical composition comprising it, process for the preparation thereof and uses thereof as a medicament
GB0326632D0 (en) * 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
EP1708708A1 (en) * 2004-01-30 2006-10-11 Teva Pharmaceutical Industries Ltd. Montelukast free acid polymorphs

Also Published As

Publication number Publication date
EP1803457A1 (en) 2007-07-04
NO20083213L (no) 2008-09-26

Similar Documents

Publication Publication Date Title
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
EA201001852A1 (ru) Твердые фармацевтические составы, содержащие bibw 2992
UA96449C2 (en) Stable laquinimod preparations
MY159208A (en) A novel formulation of indomethacin
NZ595987A (en) A novel formulation of diclofenac
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
EA201291410A1 (ru) Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат
UA97161C2 (ru) Фармацевтическая композиция, которая содержит дигидропиридиновый антагонист кальциевого канала лерканидипин и коллоидный диоксид кремния, способ ее приготовления
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
ATE488225T1 (de) Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff
CA2535013A1 (en) Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
CA2490335A1 (en) Pharmaceutical composition as solid dosage form and method for manufacturing thereof
PL408608A1 (pl) Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
MA37524A1 (fr) Procedes de production de chlorhydrate d'anamoreline presentant une teneur en chlorure regulee
WO2007110765A3 (en) Processes for the preparation of octreotide
IN2013MU01177A (ru)
UA97355C2 (ru) Фармацевтическая композиция, включающая монтелукаст
PT1853232E (pt) Forma cristalina estável de mesilato de bifeprunox, suas formas de dosagem e métodos para a sua utilização
EA201170583A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
TW200727892A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof
UA93355C2 (ru) Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения